Premier Marinas are delighted to announce that Chichester Marina's annual Boat Show will return this summer. Building on the success of previous years, the show will be held on the 26th and 27th June and will be a 'must visit' for serious buyers.
With supern on-water and onshore displays from Ancasta International Boat Sales, Blackrock Yachting, Boat Shop and RBS Marine, it will be a great opportunity for visitors to get close and personal with the boats and talk to experts who have a real passion for their brands.
Marina Manager, Paul Cook said:
"This years show will be a celebratory occassion, showcasing our onsite marina businesses which make up the community here at Chichester Marina. We will still have various precautions in place to ensure visitors have the opportunity to view boats they want to see in a safe and relaxed environment. We were dissapointed when we were forced to cancel last year's show because of Covid-19, however, the health and safety of our customers, tenants and staff was of paramount importance".
Onther onsite businesses attending the show include sailing and life-style clothing retailer Coastal and Outdoor Living, Chichester Yacht Club, Roger Upham Marine Electronics and RYA Training Centre, Chichester Marine Training. A team member from Premier Marinas will also be on hand to provide visitors with a quote and information on berthing options at Chichester Marina or at one of Premier's other eight sites.
Established in 1994, Premier Marinas owns and operates nine of the UK's most prestigious marinas. All based on the South Coast, locations include: Eastbourne, Brighton, Chichester, Southsea, Port Solent, Gosport, Swanwick, Noss on Dart and Falmouth in Cornwall. With over 5,000 berths combined, Premier Marinas strive to be the finest marina operator in the UK, providing first-class boat storage services and quality boatyard facilities at all its marinas.
Premier Marinas is owned by the Wellcome Trust, a global charitable foundation that exists to improve health for everyone. Wellcome has a diversified investment portfolio and a long-term approach to investment, as a result of which it aims to spend around £1 billion a year supporting scientists and researchers in biomedicine, the humanities and the social sciences, and public engagement and education in these fields.